PRAX-562
PRAX-562-221
Phase 3 small_molecule active
Quick answer
PRAX-562 for SCN2A Encephalopathy is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- SCN2A Encephalopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active